Study of XL820 Given Orally Daily to Subjects With Solid Tumors
NCT00350831 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2008-08-18
Summary
The purpose of this study is to assess the safety and tolerability of the KIT inhibitor XL820 when given orally daily to adults with advanced solid tumors.
Conditions
Interventions
- DRUG
-
XL820
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-07-31
Countries
- United States
Study Locations
More Related Trials
-
Safety Study of Pharmacokinetics of XL888 in Adults With Solid Tumors
NCT00796484 ·Status: TERMINATED ·Phase: PHASE1
-
Safety, Tolerability & PK of KX2-361 in Subjects w Adv. Malignancies Refractory to Conventional Therapies
NCT02326441 ·Status: COMPLETED ·Phase: PHASE1
-
Open-Label Study to Assess the Safety/Tolerability in Patients With Solid Tumors
NCT00820560 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Evaluates the Safety, Pharmacokinetics and Efficacy of WX-0593 in Advanced Solid Tumor Patients
NCT03389815 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors
NCT07123103 ·Status: RECRUITING ·Phase: PHASE1
-
KX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to Treatment
NCT00646139 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety and Pharmacokinetics of CDX-0158 in Adult Patients With Advanced Solid Tumors
NCT02642016 ·Status: COMPLETED ·Phase: PHASE1
-
Study of XL418 in Adults With Solid Tumors
NCT00460278 ·Status: SUSPENDED ·Phase: PHASE1
-
Study of AS1411 in Advanced Solid Tumours
NCT00881244 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacokinetics of XL647 Administered Orally to Subjects With Solid Tumors
NCT00086528 ·Status: COMPLETED ·Phase: PHASE1
-
Study of XL999 in Adults With Solid Tumors
NCT00104117 ·Status: COMPLETED ·Phase: PHASE1
-
BIBX 1382 in Treating Patients With Solid Tumors
NCT00003980 ·Status: SUSPENDED ·Phase: PHASE1
-
A Study of XS-02 Capsules in Patients With Advanced Solid Tumors
NCT06531486 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Phase 1 Multiple Ascending Dose Study of BMS-833923 (XL139) in Subjects With Solid Tumors
NCT01413906 ·Status: COMPLETED ·Phase: PHASE1
-
Study of XL281 in Adults With Solid Tumors
NCT00451880 ·Status: COMPLETED ·Phase: PHASE1
-
Lurtotecan Liposome in Treating Patients With Advanced Solid Tumors
NCT00003891 ·Status: COMPLETED ·Phase: PHASE1
-
Study of XL228 Administered Intravenously to Subjects With Advanced Malignancies
NCT00526838 ·Status: TERMINATED ·Phase: PHASE1
-
Study of XL647 Administered Orally Daily to Patients With Solid Tumors
NCT00336765 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacokinetic Study of RRx-001 in Cancer Subjects
NCT01359982 ·Status: COMPLETED ·Phase: PHASE1
-
The Tolerability and Pharmacokinetics of HX301 Monolactate Capsules in Patients With Advanced Solid Tumors
NCT05731934 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Antitumor Activity of KN046 in Subjects With Advanced Solid Tumors
NCT03529526 ·Status: UNKNOWN ·Phase: PHASE1
-
XTX301 in Patients With Advanced Solid Tumors
NCT05684965 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Subjects With Advanced or Metastatic Solid Tumor Malignancies
NCT05474859 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Safety of BKM120 Monotherapy in Advanced Solid Tumor Patients
NCT01068483 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, PK, Dosimetry, MTD and Preliminary Efficacy of Intra-lesionally Injected AvidinOX, Followed by IV Escalating Doses of [177Lu]DOTA-biotin in Pts With Injectable Solid Tumors or Lymphomas
NCT03188328 ·Status: TERMINATED ·Phase: PHASE1